Published in Clin Exp Allergy on May 01, 1997
Association studies for asthma and atopic diseases: a comprehensive review of the literature. Respir Res (2003) 1.39
Genome-wide and follow-up studies identify CEP68 gene variants associated with risk of aspirin-intolerant asthma. PLoS One (2010) 0.97
Short ragweed allergen induces eosinophilic lung disease in HLA-DQ transgenic mice. J Clin Invest (1999) 0.95
Unraveling the genetic basis of aspirin hypersensitivity in asthma beyond arachidonate pathways. Allergy Asthma Immunol Res (2013) 0.93
Gene-environment interactions in asthma. Occup Environ Med (2006) 0.91
Genetic markers for differentiating aspirin-hypersensitivity. Yonsei Med J (2006) 0.90
Genome-wide association study of aspirin-exacerbated respiratory disease in a Korean population. Hum Genet (2012) 0.87
Isotype and IgG subclass distribution of autoantibody response to alpha-enolase protein in adult patients with severe asthma. Yonsei Med J (2008) 0.86
Nonsteroidal anti-inflammatory drug hypersensitivity in preschool children. Allergy Asthma Clin Immunol (2007) 0.85
Differential gene expression profile in PBMCs from subjects with AERD and ATA: a gene marker for AERD. Mol Genet Genomics (2012) 0.83
Rhinosinusitis and aspirin-exacerbated respiratory disease. J Allergy (Cairo) (2012) 0.80
Aspirin-exacerbated respiratory disease: pathophysiological insights and clinical advances. J Asthma Allergy (2016) 0.78
Genetic mechanisms in aspirin-exacerbated respiratory disease. J Allergy (Cairo) (2011) 0.78
Development of a genetic marker set to diagnose aspirin-exacerbated respiratory disease in a genome-wide association study. Pharmacogenomics J (2015) 0.77
Exonic variants associated with development of aspirin exacerbated respiratory diseases. PLoS One (2014) 0.76
The SNP rs3128965 of HLA-DPB1 as a genetic marker of the AERD phenotype. PLoS One (2014) 0.76
Circulating autoantibodies in patients with aspirin-intolerant asthma: an epiphenomenon related to airway inflammation. J Korean Med Sci (2006) 0.75
Hypersensitivity to Aspirin and other NSAIDs: Diagnostic Approach in Patients with Chronic Rhinosinusitis. Curr Allergy Asthma Rep (2015) 0.75
What we know about nonsteroidal anti-inflammatory drug hypersensitivity. Korean J Intern Med (2016) 0.75
Pharmacogenomics of off-target adverse drug reactions. Br J Clin Pharmacol (2017) 0.75
A general test of association for quantitative traits in nuclear families. Am J Hum Genet (2000) 22.45
GOLD--graphical overview of linkage disequilibrium. Bioinformatics (2000) 9.43
GRR: graphical representation of relationship errors. Bioinformatics (2001) 6.09
Pedigree tests of transmission disequilibrium. Eur J Hum Genet (2000) 5.93
Extent and distribution of linkage disequilibrium in three genomic regions. Am J Hum Genet (2000) 3.68
A genome-wide search for quantitative trait loci underlying asthma. Nature (1996) 3.58
Association between atopy and variants of the beta subunit of the high-affinity immunoglobulin E receptor. Nat Genet (1994) 2.91
Localisation of atopy and beta subunit of high-affinity IgE receptor (Fc epsilon RI) on chromosome 11q. Lancet (1993) 2.88
Single nucleotide polymorphism and linkage disequilibrium within the TCR alpha/delta locus. Hum Mol Genet (2000) 2.51
Enhanced expression of cyclo-oxygenase isoenzyme 2 (COX-2) in asthmatic airways and its cellular distribution in aspirin-sensitive asthma. Thorax (1997) 2.46
Association analysis in a variance components framework. Genet Epidemiol (2001) 2.38
Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs. Allergy (2013) 2.35
Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. Br Med J (1975) 2.29
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol (2012) 2.17
Adult familial cryptogenic fibrosing alveolitis in the United Kingdom. Thorax (2000) 2.16
Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Clin Invest (1998) 2.13
Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma. Eur Respir J (2000) 2.00
Clinical patterns of hypersensitivity to nonsteroidal anti-inflammatory drugs and their pathogenesis. J Allergy Clin Immunol (1977) 1.88
Independent inheritance of serum immunoglobulin E concentrations and airway responsiveness. Am J Respir Crit Care Med (2000) 1.80
Plasma 9alpha,11beta-PGF2, a PGD2 metabolite, as a sensitive marker of mast cell activation by allergen in bronchial asthma. Thorax (2004) 1.80
Genetic variance components analysis for binary phenotypes using generalized linear mixed models (GLMMs) and Gibbs sampling. Genet Epidemiol (1999) 1.77
Association of atopic dermatitis to the beta subunit of the high affinity immunoglobulin E receptor. Br J Dermatol (1998) 1.69
Safety of a specific COX-2 inhibitor in aspirin-induced asthma. Clin Exp Allergy (2001) 1.67
Gene polymorphism in Netherton and common atopic disease. Nat Genet (2001) 1.66
The power to detect linkage disequilibrium with quantitative traits in selected samples. Am J Hum Genet (2001) 1.64
Lipoprotein(a) as a modifier of fibrin clot permeability and susceptibility to lysis. J Thromb Haemost (2006) 1.61
Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor V, and factor XIII and by enhancing factor Va inactivation. Circulation (2001) 1.61
Cardiac arrhythmias caused by nebulised beta-agonist therapy. Lancet (1987) 1.57
Successful therapy of advanced arteriosclerosis obliterans with prostacyclin. Lancet (1979) 1.57
HLA-DR and HLA-DP genotypes and immunoglobulin E responses to common major allergens. Clin Exp Allergy (1994) 1.56
Blood coagulation at the site of microvascular injury: effects of low-dose aspirin. Blood (2001) 1.54
EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy (2007) 1.53
Tumour necrosis factor haplotypes and asthma. Hum Mol Genet (1997) 1.48
Prostaglandin E2 systemic production in patients with asthma with and without aspirin hypersensitivity. Thorax (2007) 1.48
Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma. Lancet (1997) 1.43
Inhibition of thrombin generation by aspirin. Thromb Haemost (1994) 1.40
Fc epsilon RI-beta polymorphism and risk of atopy in a general population sample. BMJ (1995) 1.40
Confirmation of genetic linkage between atopic IgE responses and chromosome 11q13. J Med Genet (1992) 1.32
Compensation, radiographic changes, and survival in applicants for asbestosis compensation. Br J Ind Med (1985) 1.31
Influence of the HLA-DRB1 locus on susceptibility and severity in rheumatoid arthritis. QJM (1996) 1.31
Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) - classification, diagnosis and management: review of the EAACI/ENDA(#) and GA2LEN/HANNA*. Allergy (2011) 1.30
Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics. Eur Respir J (2000) 1.29
Investigation of an interleukin-4 promoter polymorphism for associations with asthma and atopy. J Med Genet (1996) 1.28
A new variant of the beta subunit of the high-affinity receptor for immunoglobulin E (Fc epsilon RI-beta E237G): associations with measures of atopy and bronchial hyper-responsiveness. Hum Mol Genet (1996) 1.27
Anti-inflammatory effects of simvastatin in subjects with hypercholesterolemia. Int J Cardiol (2001) 1.25
Aspirin-induced asthma. Hypersensitivity to fenoprofen and ibuprofen in relation to their inhibitory action on prostaglandin generation by different microsomal enzymic preparations. J Allergy Clin Immunol (1976) 1.25
Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics. Am J Respir Crit Care Med (1998) 1.24
Asthma relieved by aspirin and by other cyclo-oxygenase inhibitors. Thorax (1978) 1.24
Enhanced expression of the leukotriene C(4) synthase due to overactive transcription of an allelic variant associated with aspirin-intolerant asthma. Am J Respir Cell Mol Biol (2000) 1.22
Regional cerebral blood flow in fibromyalgia: single-photon-emission computed tomography evidence of reduction in the pontine tegmentum and thalami. Arthritis Rheum (2000) 1.20
Symptoms and longitudinal changes in lung function in young seasonal grain handlers. Br J Ind Med (1986) 1.15
Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma. Eur Respir J (2000) 1.13
Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes. Ann Allergy Asthma Immunol (2001) 1.13
Cysteinyl leukotrienes overproduction and mast cell activation in aspirin-provoked bronchospasm in asthma. Eur Respir J (1993) 1.13
Delta 32 deletion of CCR5 gene and association with asthma or atopy. Lancet (2000) 1.12
The effect of six prostaglandins, prostacyclin and iloprost on generation of superoxide anions by human polymorphonuclear leukocytes stimulated by zymosan or formyl-methionyl-leucyl-phenylalanine. Biochem Pharmacol (1987) 1.12
Prevalence of asthma with aspirin hypersensitivity in the adult population of Poland. Allergy (2003) 1.11
Prevalence of radiographic asbestosis in crocidolite miners and millers at Wittenoom, Western Australia. Br J Ind Med (1986) 1.11
Haemodynamic changes induced by prostacyclin in man. Br Heart J (1980) 1.11
Statins, fenofibrate, and quinapril increase clot permeability and enhance fibrinolysis in patients with coronary artery disease. J Thromb Haemost (2006) 1.10
Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics. Am J Respir Crit Care Med (1996) 1.09
Important research questions in allergy and related diseases: 3-chronic rhinosinusitis and nasal polyposis - a GALEN study. Allergy (2009) 1.08
The effect of genotype and pedigree error on linkage analysis: analysis of three asthma genome scans. Genet Epidemiol (2001) 1.08
Urinary leukotriene E4 after lysine-aspirin inhalation in asthmatic subjects. Am Rev Respir Dis (1992) 1.08
The genetics of asthma. Maternal effects in atopic disease. Clin Exp Allergy (1998) 1.07
Atopy, non-allergic bronchial reactivity, and past history as determinants of work related symptoms in seasonal grain handlers. Br J Ind Med (1986) 1.06
Inhalation of amiloride improves the mucociliary and the cough clearance in patients with cystic fibroses. Eur J Respir Dis Suppl (1986) 1.06
Increases in airway responsiveness to histamine precede allergen-induced late asthmatic responses. J Allergy Clin Immunol (1988) 1.06
Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge. Am J Respir Crit Care Med (1994) 1.05
Autoimmune phenomena in bronchial asthma with special reference to aspirin intolerance. Am J Respir Crit Care Med (1995) 1.05
Association between quantitative traits underlying asthma and the HLA-DRB1 locus in a family-based population sample. Eur J Hum Genet (2001) 1.04
Inflammatory cell populations in bronchial biopsies from aspirin-sensitive asthmatic subjects. Am J Respir Crit Care Med (1996) 1.03
Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma. J Allergy Clin Immunol (1998) 1.03
Linkage of chromosome 5q and 11q gene markers to asthma-associated quantitative traits in Australian children. Am J Respir Crit Care Med (1998) 1.01
Mechanisms of virus-induced asthma exacerbations: state-of-the-art. A GA2LEN and InterAirways document. Allergy (2007) 1.01
The atopy trait in hypersensitivity to nonsteroidal anti-inflammatory drugs. Allergy (1996) 1.00
Pl(A2) polymorphism of beta(3) integrins is associated with enhanced thrombin generation and impaired antithrombotic action of aspirin at the site of microvascular injury. Circulation (2001) 1.00
Dysgerminoma, gonadoblastoma, and testicular germ cell neoplasia in phenotypically female and male siblings with 46 XY genotype. Cancer (1987) 0.99
Familial aggregation and heritability of asthma-associated quantitative traits in a population-based sample of nuclear families. Eur J Hum Genet (2000) 0.98
Bronchodilatory properties of 2-decarboxy-2-hydroxymethyl prostaglandin E1. Prostaglandins (1985) 0.98
Benign and malignant pleural effusions in former Wittenoom crocidolite millers and miners. Aust N Z J Med (1985) 0.98
Prostacyclin for pulmonary hypertension. Lancet (1980) 0.98
Factors confounding genetic linkage between atopy and chromosome 11q. Clin Exp Allergy (1992) 0.96
Treatment of hyperhomocysteinemia with folic acid and vitamins B12 and B6 attenuates thrombin generation. Thromb Res (1999) 0.96
Airway responsiveness to leukotriene C4 (LTC4), leukotriene E4 (LTE4) and histamine in aspirin-sensitive asthmatic subjects. Eur Respir J (1993) 0.96